Annual report pursuant to Section 13 and 15(d)

Investments in unconsolidated entities - Additional Information (Detail)

v2.4.0.8
Investments in unconsolidated entities - Additional Information (Detail) (USD $)
12 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Nephromics, LLC
Jun. 30, 2013
Nephromics, LLC
Apr. 30, 2013
H2Equity, LLC
Jun. 30, 2013
H2Equity, LLC
Jun. 30, 2012
H2Equity, LLC
Jul. 31, 2013
H2Equity, LLC
Subsequent Event
Jun. 30, 2012
ACTGen, Inc.
Investments in and Advances to Affiliates [Line Items]                    
Percentage of investment in equity interest         16.80%   6.50%      
Net investment on a cost basis $ 0 $ 3,254,000 $ 0 $ 2,400,000           $ 854,000
Net investment under equity method       505,000 505,000   26,000 551,000    
Distribution received 1,095,000 463,000 0     1,100,000     26,000  
Gain on sale of investment assets           $ 708,000